Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1998
03/12/1998CA2259959A1 Modulators of brca1 activity
03/11/1998EP0828003A2 Human serine protease
03/11/1998EP0827968A2 Bioactive substance having antitumor activity, producing strain, production ans use thereof
03/11/1998EP0827628A1 Methods and apparatus for sequencing polymers with a statistical certainty using mass spectrometry
03/11/1998EP0827591A1 Method for diagnosing a patient for chlamydia
03/11/1998EP0827544A2 Multimeric proteins
03/11/1998EP0827540A1 Transgenic animal models for type ii diabetes mellitus
03/11/1998EP0827539A2 Kunitz type protease inhibitors
03/11/1998EP0827512A1 ANTIBODY SPECIFIC FOR $i(STAPHYLOCOCCUS AUREUS), AND USE THEREOF
03/11/1998EP0827509A1 Modulation of cholesteryl ester transfer protein (cetp) activity
03/11/1998CN1175977A Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw* 1601 and uses thereof
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175957A Monoclonal antibodies anti-CD6 and their uses
03/11/1998CN1175956A Novel protein and method for production of same
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/11/1998CN1175586A Gene structure with calcitonin gene related peptide (CGRP) and preparing method thereof
03/10/1998US5726304 Porphocyanine and CNC-expanded porphyrins
03/10/1998US5726298 Epimorphin and its encoding nucleic acids
03/10/1998US5726290 Soluble analogues of integrins
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5726044 Expression and export technology of proteins as immunofusins
03/10/1998US5726043 Process for the production of protease inhibitors
03/10/1998US5726039 Vectors and transformed host cells for recombinant protein production at reduced temperatures
03/10/1998US5726038 DNA construct encoding the YAP3 signal peptide
03/10/1998US5726037 Host cells and method of producing soluble analogues of integrins
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5726035 Recombinant production of mammalian calcium channel gamma subunits
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5725862 Vaccine for branhamelia catarrhalis
03/10/1998US5725858 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein
03/10/1998US5725855 Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
03/10/1998US5725851 Method and compositions for treating injury
03/10/1998CA1339709C Monoclonal antibodies to human pancreatic cancer
03/10/1998CA1339707C Formulations for recombinant beta-interferon
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
03/05/1998WO1998008964A1 Mammalian artificial chromosomes
03/05/1998WO1998008959A1 In vivo protein synthesis method
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008954A2 Production of heme and recombinant hemoproteins
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008945A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998WO1998008936A1 Recombinant canine herpesvirus
03/05/1998WO1998008934A1 Serum-free mammalian cell culture medium, and uses thereof
03/05/1998WO1998008933A1 Kuz, a novel family of metalloproteases
03/05/1998WO1998008874A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
03/05/1998WO1998008872A1 Glp-2 derivatives
03/05/1998WO1998008870A1 Interleukin-19
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008540A1 Multivalent vaccine for clostridium botulinum neurotoxin
03/05/1998WO1998008371A1 Monoclonal antibodies specific to cooked meats
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001553A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/05/1998CA2296765A1 Soluble recombinant botulinum toxin proteins
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264576A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998CA2264550A1 In vivo protein synthesis method
03/05/1998CA2264548A1 Interleukin-19
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263819A1 Insecticidal protein toxins from photorhabdus
03/04/1998EP0826775A1 Vector system for conditional gene expression
03/04/1998EP0826772A2 Human mucin (MUC8)
03/04/1998EP0826310A1 FEED COMPOSITION CONTAINING POLY-$g(g)-GLUTAMIC ACID
03/04/1998EP0826064A1 Low oxygen affinity mutant hemoglobin
03/04/1998EP0826060A2 Embedded expression of heterologous proteins
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826052A1 High molecular weight major outer membrane protein of moraxella
03/04/1998EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826044A1 Bmp-15 compositions
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826033A1 Ataxia-telangiectasia gene
03/04/1998EP0826006A1 Transeptithelial transport of molecular species
03/04/1998EP0826002A2 Biologically active peptide fragments of ob protein
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825811A1 Non-genetically modified mammal as a model for multiple sclerosis
03/04/1998EP0662129B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
03/04/1998EP0656121B1 Method for diagnosing and monitoring sepsis
03/04/1998EP0644948B1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor
03/04/1998EP0554389B1 Molecular clones of hiv-1 and uses thereof
03/04/1998EP0542949B1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines
03/04/1998EP0390799B1 Respiratory syncytial virus: vaccines
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175262A Novel receptor
03/03/1998US5723760 Genetic engineering
03/03/1998US5723759 Pyrrolnitrin biosynthesis genes
03/03/1998US5723756 Genetic engineering
03/03/1998US5723585 Method of purifying cardiac hypertrophy factor
03/03/1998US5723583 Antibody containing sialyl lewis X determinants
03/03/1998US5723441 Method of treating renal disease by administering IGF-I and IGFBP-3
03/03/1998US5723437 Glycoproteins and cell surfaces and scavenger receptors
03/03/1998US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
03/03/1998US5723333 Vectors of oncogenes, promoters, transcription
03/03/1998US5723332 Translational enhancer DNA
03/03/1998US5723329 DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells
03/03/1998US5723326 Genome coding phytolacca antiviral protein and a recombinant expression vector therefor